# The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study

> **NCT05165082** · NA · COMPLETED · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 8 (actual)

## Conditions studied

- Paronychia
- Epidermal Growth Factor Receptor Inhibitor

## Interventions

- **DRUG:** Timolol maleate 0.5% ophthalmic solution
- **PROCEDURE:** Cryotherapy with liquid nitrogen

## Key facts

- **NCT ID:** NCT05165082
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-21
- **Primary completion:** 2023-01-21
- **Final completion:** 2023-03-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05165082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05165082, "The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05165082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*